FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer

被引：3
|
作者：
Hoopes, D
Tann, M
McGarry, R
Lo, S
Timmerman, R
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.385
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1131
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [1] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
    Hoopes, David J.
    Tann, Mark
    Fletcher, James W.
    Forquer, Jeffrey A.
    Lin, Pei-Fen
    Lo, Simon S.
    Timmerman, Robert D.
    McGarry, Ronald C.
    [J]. LUNG CANCER, 2007, 56 (02) : 229 - 234
  • [2] Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?
    Clarke, Katy
    Taremi, Mojgan
    Dahele, Max
    Freeman, Marc
    Fung, Sharon
    Franks, Kevin
    Bezjak, Andrea
    Brade, Anthony
    Cho, John
    Hope, Andrew
    Sun, Alexander
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 62 - 66
  • [3] Stereotactic Body Radiotherapy (SBRT) for Non-small Cell Lung Cancer (NSCLC) -is FDG-PET a Predictor of Outcome?
    Clarke, K. L.
    Taremi, M.
    Freeman, M.
    Fung, S.
    Dahele, M.
    Bezjak, A.
    Brade, A.
    Cho, J.
    Hope, A.
    Sun, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S499 - S500
  • [4] FDG-PET parameters as predictors for outcome in non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT)
    Alzouebi, M.
    Subesinghe, M.
    Snee, M.
    Young, C.
    Turner, R.
    Stuart, R.
    Franks, K.
    Ramasamy, S.
    Thygesen, H.
    Clarke, K. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S807 - S807
  • [5] FDG-PET SUV UPTAKE AS A PREDICTOR OF OUTCOME IN STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR NON - SMALL CELL LUNG CANCER(NSCLC)
    Clarke, Katy
    Taremi, Mojgan
    Freeman, Marc
    Fung, Sharon
    Dahele, Max
    Bezjak, Andrea
    Brade, Anthony
    Cho, John
    Hope, Andrew
    Sun, Alexander
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S544 - S545
  • [6] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    Ceniceros, L.
    Aristu, J.
    Castanon, E.
    Rolfo, C.
    Legaspi, J.
    Olarte, A.
    Valtuena, G.
    Moreno, M.
    Gil-Bazo, I.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (03): : 259 - 268
  • [7] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    L. Ceniceros
    J. Aristu
    E. Castañón
    C. Rolfo
    J. Legaspi
    A. Olarte
    G. Valtueña
    M. Moreno
    I. Gil-Bazo
    [J]. Clinical and Translational Oncology, 2016, 18 : 259 - 268
  • [8] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Martel-Lafay, I.
    [J]. ONCOLOGIE, 2012, 14 (05) : 282 - 288
  • [9] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Slotman, Ben J.
    [J]. JOURNAL OF RADIOSURGERY AND SBRT, 2011, 1 (01): : 63 - 69
  • [10] FDG PET SUV UPTAKE IN STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR NON - SMALL CELL LUNG CANCER (NSCLC)
    Clarke, K.
    Taremi, M.
    Freeman, M.
    Fung, S.
    Bico-Ponce, J.
    Bezjak, A.
    Brade, A.
    Hope, A.
    Cho, J.
    Franks, K.
    Dahele, M.
    Sun, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S57 - S58
12345